Reuters - Pfizer Inc may bid for Ranbaxy
Laboratories Ltd, countering a $4.6 billion offer by Japan’s
Daiichi Sankyo Co Ltd for the Indian generic drug maker, the
Business Standard newspaper said.
Independent honest reviews of most effective natural herbal supplements
Reuters - Pfizer Inc may bid for Ranbaxy
Laboratories Ltd, countering a $4.6 billion offer by Japan’s
Daiichi Sankyo Co Ltd for the Indian generic drug maker, the
Business Standard newspaper said.
The URI to TrackBack this entry is: http://herbal-review.com/2008/06/13/pfizer-may-make-counter-bid-for-ranbaxy-report-reuters/trackback/
Please healthy :)
You must be logged in to post a comment.
|No results yet!
23 queries. 6.942 seconds